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Abstract
Targeted and non-targeted metabolite profiling can identify biomarkers after 
a dietary treatment leading to a better understanding of interactions between diet 
and health. This study was conducted to establish enriched or depleted metabolites 
in the feces of overweight mice after a diet shift plus agavins or inulins supple-
mentation, and their possible association with beneficial effects on host health. 
Thirty-eight male C57BL/6 mice were fed with a high-fat diet for 5 weeks followed 
by a diet shift to a standard diet supplemented with agavins (HF-ST + A) or inulins 
(HF-ST + I) for five more weeks. Feces were collected before and after prebiotic 
supplementation for metabolomics analyses. HF-ST + I group increased the fecal 
excretion of two methyl esters: linoleic and oleic acid, while HF-ST + A mice 
showed a substantial augment of 2-decenal, fructose, cyclohexanol, and the acids: 
10-undecenoic, 3-phenyllactic, nicotinic, 5-hydroxyvaleric, and lactic. From the 
metabolites identified in HF-ST + A, only lactic acid has been reported previously 
and associated with beneficial effects on host health. However, the identification of 
new metabolites, coming from the microbial fermentation of agavins, opens oppor-
tunities to transform this information into practical solutions to tackle overweight 
and associated metabolic syndrome.
Keywords: agavins, branched neo-fructans, metabolomics, postbiotics, prebiotics, 
overweight, fecal metabolites, biomarkers
1. Introduction
In the last decade, an increasing number of studies have been strongly associ-
ated with a high-fat consumption altering the gut microbiota composition and/or 
its functionality [1, 2]. It has also been related to overweight and obesity as well as 
the metabolic syndrome [3–5]. Overweight and obesity not only affects the wellbe-
ing of an individual but also places an unwanted economic burden on society [6]. 
Therefore, it is necessary and urgent to find an effective way to prevent and/or treat 
these worldwide pathologies. In this sense, prebiotics might be a good nutritional 
alternative in the management of overweight and obesity and its associated meta-
bolic syndrome, since their supplementation or consumption can modulate the 
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gut microbiota producing a wide range of metabolites (postbiotics), consequently 
generating positive effects on host health [6, 7].
Agavins are relatively new prebiotics that in pre-clinical studies have shown 
several beneficial effects on the health of individuals [8–10]. Agavins are neo-fruc-
tans composed of complex and highly branched molecules with β(2–1) and β(2–6) 
linkages as well as an internal glucose unit [11, 12].
Our research group has evidenced that agavins can decrease glucose, triglycer-
ides, and cholesterol concentrations as well as increase the anorexigenic peptide 
glucagon-like peptide1 (GLP-1; appetite-suppressing peptide) secretion on mice 
fed with a normal diet [8, 9]. Moreover, recently, we reported that agavins intake 
led to the reversion of metabolic disorders in overweight mice (induced by high-
fat diet consumption) and also a substantial decrement of orexigenic peptide 
ghrelin (appetite-stimulating) and adipokines (leptin and insulin) levels in the 
portal vein, in such a way that all mice showed an integral improvement on their 
health [10].
On the other hand, due to the structural complexity of agavins, they cannot be 
degraded by endogenous gastrointestinal enzymes during their passage through the 
stomach and the small intestine; so, they reach the colon structurally unchanged, 
where they are fermented by the gut microbiota present in this organ [13, 14]. 
Fermentation of complex carbohydrates, such as agavins, might involve the col-
laboration of a highly diverse selection of gut microbes, which produce a myriad of 
different metabolites (postbiotics) that are suggested as key links in the communi-
cation between bacterial communities of the gut and the host [15, 16]. Nonetheless, 
only short-chain fatty acids (SCFA) such as acetate, propionate, butyrate, lactate, 
and succinate are among the metabolites reported up to now, derived from the 
agavins fermentation in in vitro and/or in vivo studies [9, 10, 17, 18]; the generation 
of these acids has been associated with different beneficial effects in the context of 
obesity, since SCFA reduce body weight gain, through G-protein-coupled receptors 
(GPRs), influencing the secretion of hormones involved in appetite control [19–21]. 
Moreover, SCFA are used as energy sources and may contribute to several metabolic 
pathways, including gluconeogenesis [22] and lipogenesis [23], thus contributing to 
whole-body energy homeostasis.
In spite of the above, other secondary metabolic products from the microbiota 
such as amino acids, nucleotides, bile acids, phenolic acids, fatty acids, and sterols, 
to mention some, can come from the agavins-microbiota interactions that have yet 
to be established. In the last decades, developed metabolomic tools have allowed 
researchers to study and characterize a wide range of metabolites in a non-invasive 
manner and also on biological systems, obtaining a large set of metabolites (metab-
olomics) that derive from gut microbes, enriched or depleted, after a dietary inter-
vention [24]. This area of studies has been increased on the last decade, since this 
opens an opportunity to propose new biomarkers with new therapeutic approaches, 
through selective alterations of microbial production molecules to promote host 
health and prevent diseases [25].
In the present work, we established general and unique metabolites in 
overweight mice after agavins intake. We have previously showed that agavins 
consumption by overweight mice led to a gut microbiota modulation (these 
changes differed from those originated by inulins intake [14]); then, we 
hypothesized that agavins structure and the changes in the composition of gut 
microbiota in relation to inulins could lead to changes in colonic metabolic 
activity. The identification of microbial metabolites derived exclusively from 
agavins consumption may help to propose new biomarkers with huge potential 
and applicability on the prevention and/or treatment of overweight and their 
comorbidities.
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2. Materials and methods
2.1 Animals and diets
Thirty-eight male C57BL/6 mice (12 weeks old at the beginning of the experi-
ment were obtained from Universidad Autonoma Metropolitana, Mexico city, 
Mexico) and housed in a temperature and humidity controlled room with a 12-h 
light–dark cycles. Mice were maintained in individual cages and subject to two 
experimental phases, to gain and loss weight, respectively. In the first phase, 
mice were fed with a high-fat diet (n = 30; 58Y1 Test Diet, St. Louis, MO, USA) 
for 5 weeks to induce overweight in the animals. In the second phase, overweight 
mice (HF) were shifted to the standard diet (5053 Lab Diet, St. Louis, MO, USA) 
alone (HF-ST; n = 8) or supplemented with agavins (HF-ST + A; n = 8) or inulins 
(HF-ST + I; n = 8) for five more weeks. Moreover, we had a healthy control group of 
mice (ST; n = 8), which were fed with the standard diet (5053 Lab Diet, St. Louis, 
MO, USA) throughout the experiment.
The high-fat diet (58Y1 Test Diet) had 20.3% calories from carbohydrates 
(16.15% maltodextrin, 8.85% sucrose, and 6.46% powdered cellulose), 18.1% 
from proteins, and 61.6% from fat (31.7% lard and 3.2% soybean oil), whereas the 
standard diet (5053 Lab Diet) contained 62.4% calories from carbohydrates (28.6% 
starch, 3.24% sucrose, 1.34% lactose, 0.24% fructose, and 0.19% glucose), 24.5% 
from proteins, and 13.1% from fat.
Food and water were provided at libitum along the experiment. Mice experi-
ments were conducted according to the Mexican Norm NOM-062-ZOO-1999 and 
approved by the Institutional Care and Use of Laboratory Animals Committee from 
Cinvestav-Mexico (CICUAL; protocol number 0091-14).
2.2 Agavins and inulins
Agavins from 4-year-old Agave tequilana Weber blue variety plants were 
extracted and purified in our laboratory and presented an average degree polymer-
ization (DP) of 8, whereas inulins (oligofructose) was bought from Megafarma® 
(Mexico city, Mexico) and possess an average DP of 5. Agavins and inulins were 
added in the water at a concentration of 0.38 g/mouse/day [10].
2.3  Feces collection and preparation for untargeted and organic acids metabolic 
analyses
Feces were collected from each mouse at the end of the first and second experi-
mental phases, before and after prebiotic supplementation, respectively. The feces 
of mice were pooled by treatment, lyophilized, triturated, and homogenized to 
generate fecal metabolites profiles. Untargeted metabolic analysis was carried out 
following a method adjusted from Eneroth et al. [26] and Gao et al. [27] as follows: 
100 mg of feces were extracted tree times with chloroform/methanol (2:1), 1 mL 
each time. After that, the extracts were combined and solvent freed. The residue 
was resuspended in 1 mL of chloroform/methanol (2:1) and an aliquot of 50 μL was 
transferred to a vial. The aliquot was solvent freed under nitrogen flux and then was 
derivatized using BSTFA with 1% TCMS (80 μL) and pyridine (20 μL) at 80°C for 
25 min. Once the system was at room temperature, isooctane was added to a final 
volume of 200 μL. Heptadecanoic acid, at final concentration of 3 mg/mL, was used 
as internal standard.
On the other hand, extraction of organic acids was performed according to 
García-Villalba et al. [28]. Briefly, 100 mg of feces were suspended in 1 mL of 
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aqueous 0.5% phosphoric acid solution and mixed in vortex for 2 min. After that, 
samples were centrifuged for 10 min at 10,000 g. Then, the supernatant was trans-
ferred to a vial and was extracted with an equal volume of ethyl acetate. 2-Methyl 
valeric acid was used as internal standard at final concentration of 2 mM. This 
system was centrifuged for 10 min at 10,000 g, and then 200 μL of the ethyl acetate 
phase were transferred to a vial, dried under nitrogen flux, and derivatized using 
80 μL of BSFTA with 1% TMCS and 20 μL of pyridine. The mix was allowed to react 
at 80°C for 25 min. After the mix was at room temperature, isooctane was added to 
a final volume of 200 μL.
2.4 Gas chromatography/mass spectrometry analysis
For GC/MS analysis, 1 μL of the organic phase was injected in the pulsed-
splitless mode. Injector temperature was set to 260°C. A HP-5-MS capillary 
column (30 m × 25 μm × 0.25 μm) was used with helium as carrier gas at constant 
flow rate of 1 mL/min. Oven program began at 40°C (held 5 min), then increased 
at rate of 6°C/min until 170°C, then a second temperature ramp of 12°C/min 
until 290°C was applied. Transfer line temperature was set at 260°C. Mass spec-
trometer operated at 70 eV of electron energy, quadrupole and ion-source tem-
peratures were 150 and 230°C, respectively. Data were obtained scanning from 
40 to 550 m/z, while MassHunter Workstation software version B.0.0.6 (Agilent 
Technologies, Inc.) was used to collect the data. Components mass spectra 
and retention times were obtained using the AMDIS (automated mass spectral 
deconvolution and identification system, http://www.amdis.net/) software. 
Compounds identification was achieved by comparing their respective extracted 
mass spectrum with the mass spectra of the standards and/or with the mass 
spectra data of the NIST library and software (National Institute of Standards and 
Technology, USA).
2.5 Statistics and data analysis
Results are present as mean ± standard deviation. Differences between the diets 
were determined using one-way ANOVA followed by a Tukey post hoc test or a Dunett 
T3 post hoc test. Differences were considered significant when p < 0.05. Statistical 
analyses were performed using the IBM SPSS Statistics software version 22. Principal 
component analysis and heatmap were conducted using a language and environment 
for statistical computing R and the ade4 and gplots packages.
3. Results and discussion
Previous studies carried out by our research group evidenced that agavins intake 
led to improvement on health and wellness of the host, which has been associ-
ated with gut microbiota modulation and their metabolic products such as SCFA 
[10, 14]; nonetheless, other bioactive chemical compounds coming from agavins 
fermentation that could also contribute with the beneficial agavins consumption 
effects are unknown yet. In the present work, we performed a metabolomics analy-
sis to establish and propose general and unique metabolites (postbiotics) in the 
feces of overweight mice after agavins (prebiotic) intake. Since it has been recom-
mended the use of combination of methodologies to extend the metabolic coverage 
of microbiota [29], we performed an untargeted metabolic as well as organic acids 
profile analyses to carry out this task.
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3.1 Untargeted metabolic profiles
Untargeted metabolic analysis showed a total of 300 metabolites, from which 
only 109 were identified completely. Those 109 compounds mainly included fatty 
acids and their esters, carbohydrates, sterols, alcohols, alkanes, SCFA, aldehydes, 
amino acids, nucleobases, bile salts, and phenylpropanoids (Table 1).
Of these 109 compounds (Table 1), 32 presented a significantly differen-
tial abundance between the different evaluated diets (Tukey’s test, p < 0.05; 
Table 2). These 32 metabolites were grouped mostly in fatty acids and sterols 
and subsequently used for the principal component analysis (PCA) and heat map 
construction.
PCA was applied to the data to investigate metabolomics changes derived from 
agavins consumption. The variance explained by each principal component (PC) 
is displayed on the X and Y axes. PC1 and PC2 account for 62.5 and 20.5% of the 
variance, respectively. Very clear and separated clusters were observed among 
overweight mice (HF) and the other mice groups, suggesting differences on fecal 
metabolomics profiling (Figure 1A). In addition, mice that received agavins  
supplement are clearly separate, into a distinct cluster, from rodents fed with inu-
lins supplementation. Interestingly, HF-ST + A group appear very close to standard 
diets (HF-ST and ST), evidencing a large similarity on metabolites among them 
compared to HF-ST + I group (Figure 1A).
Moreover, the loading plot illustrates the variables (metabolites) that are respon-
sible for the discrimination (clustering of the samples) observed in the PCA plot. 
Then, according to the loading plot, HF and HF-ST + I groups shared the PC2 due to 
high content of oleic acid, cholesterol, and stigmasterol in the feces (Figure 1B).
ID RT Compound Family
1 12.62 Cyclohexanol Alcohol
2 13.028 Carbonic acid Others
3 13.183 β-Hydroxybutyric acid βOH-SCFA
4 13.234 Heptanoic acid FA
5 13.281 α-Hydroxyvaleric acid αOH-SCFA
6 14.008 Benzaldehyde, 2,5-dimethyl- Aldehyde
7 14.049 L-Valine Amino acid
8 14.483 Urea Others
9 14.623 2-Decenal, (E)- Aldehyde
10 14.94 Glycerol Polyalcohol
11 15.074 2,5-dihydroxy hexane, 2,5-dimethyl- Polyalcohol
12 15.406 Succinic acid DiCAc
13 15.778 Uracil Nucleobase
14 16.153 Butane, 1,2,4, triol Polyalcohol
15 16.646 Thymine Nucleobase
16 16.774 Hydrocinnamic acid PhePr
17 17.096 Bicyclo[2.2.1]heptane-1-carboxylic acid, 
7-Hydroxy, methyl ester
Ester
18 17.258 Decanoic acid FA
19 17.55 Decane, 2,3,5,8-tetramethyl- Alkane
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ID RT Compound Family
20 17.666 Dodecane, 4,6-dimethyl- Alkane
21 17.741 Dodecane, 2,6,11-trimethyl- Alkane
22 17.95 2,4-Ditert-butylphenol Phenolic
23 18.011 1-Butene, 1-phenyl-3-(hydroxy)-, E Ar
24 18.168 Pyroglutamic acid Amino acid
25 18.422 2,6-Ditert-butylphenol Phenolic
26 18.642 Pentadecane Alkane
27 18.637 Undecanoic acid FA
28 18.724 Heptadecane, 2,6,10,15-tetramethyl- Alkane
29 19.173 m-Hydroxyphenylacetic acid OH-Ar-SCFA
30 19.228 Cyanuric acid Triazine
31 19.428 D-Arabinose CHO
32 19.52 p-Hydroxyphenylacetic acid OH-Ar-SCFA
33 19.599 n-Dodecanoic acid FA
34 20.172 Hexadecane, 2,6,11,15-tetramethyl- Alkane
35 20.204 Xylulose CHO
36 19.153, 20.341 D-Mannose CHO
37 20.438 10-Undecenoic acid FA
38 20.51 Benzenepropanoic acid PhePr
39 21.051 Glycerol phosphate Others
40 21.159 Tetradecanoic acid, 12-methyl-, methyl ester FAME
41 21.225 Azelaic acid DiCAc
42 19.549, 21.389 D-Galactose CHO
43 21.583, 21.652 D-Fructose CHO
44 21.345 Tetradecanoic acid FA
45 21.878 Inositol Polyalcohol
46 22.039 Adenine Nucleobase
47 22.352, 22.436 Methyl-tetradecanoic acid isomers (C15 fatty acid 
isomers)
FA
48 22.716 Pentadecanoic acid FA
49 21.966, 22.483, 
23.336
D-Glucose CHO
50 23.428 cis-9-Hexadecenoic acid FA
51 23.481 trans-9-Hexadecenoic acid FA
52 23.691 Hexadecanoic acid FA
53 24.128 Linoleic acid, methyl ester FAME
54 24.177 Oleic acid, methyl ester FAME
55 24.37 cis-10-Heptadecenoic acid FA
56 24.399 Stearic acid, methyl ester FAME
57 24.404 α-D-glucose, 2-(acetylamino)-2-deoxy CHO
58 25.102 5-Hydroxyindoleacetic acid IndolAc
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ID RT Compound Family
59 25.198 Linoleic acid FA
60 25.25 Oleic acid FA
61 25.298 trans-11-Octadecenoic acid FA
62 25.315 cis-11-Octadecenoic acid FA
63 25.481 Stearic acid FA
64 26.262 2-O-glycerol-α-D-galactose CHO
65 26.288 Nonadecanoic acid FA
66 26.546 Arachidonic acid FA
67 26.648 tert-Hexadecanethiol Thiol
68 26.716 Tetratriacontane Alkane
69 26.743 Octadecane, 3-ethyl-5-(2-ethylbutyl)- Alkane
70 26.774 Succinylacetone Others
71 26.838 Hentriacontane Alkane
72 26.9 Oleamide Amide
73 27.006 Sebacic acid DiCAc
74 27.095 Eicosanoic acid FA
75 27.509 1-O-hexadecylglycerol Glycerol-ether
76 27.584 Heneicosanoic acid FA
77 27.618 Propyl myristate Ester
78 27.716 2-Octadecenoic acid FA
79 27.866 Heneicosanoic acid FA
80 28.498 4-n-octadecylcyclohexane, 1,3,5-trimethyl- Alkane
81 28.62 Docosanoic acid FA
82 28.76 α-Hydroxy sebacic acid αOH-DiCAc
83 28.967 1-O-Octadecylglycerol Glycerol-ether
84 29.01 cis-4-Tetradecene, 2-methyl- Alkene
85 29.339 Tricosanoic acid FA
86 29.578 1-Monooleoylglycerol Monoglyceride
87 29.709 1-Docosanol Alcohol
88 29.895 cis-15-Tetracosenoic acid FA
89 28.125, 28.661, 
29.646, 29.932
Disaccharides (including sucrose) CHO
90 30.026 Octadecane, 3-ethyl-5-(2-ethylbutyl)- Alkane
91 30.221 Enterolactone Lignin
92 30.329 1-O-hexadecylglycerol Glycerol-ether
93 30.383 Tricosanol Alcohol
94 30.428 Cholesta-2,4-diene Sterol
95 30.673 Cholesta-3,5-diene Sterol
96 31.31 β-Tocopherol Vitamin
97 31.454 Hexacosanoic acid FA
98 31.891 Coprostan-3-ol Sterol
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ID RT Compound Family Fold change
HF HF-ST HF-ST + A HF-ST + I
1 12.62 Cyclohexanol Alcohol −1.00 0.10 0.57 −0.13
3 13.183 β-Hydroxybutyric acid βOH-SCFA −0.62 −0.48 0.15 0.34
4 13.234 Heptanoic acid FA −0.88 −0.39 −0.13 −0.13
5 13.281 α-Hydroxyvaleric acid αOH-SCFA −0.30 −0.18 0.56 1.10
9 14.623 2-Decenal, (E)- Aldehyde −1.00 0.18 1.79 −0.90
10 14.94 Glycerol Polyalcohol −0.90 −0.15 −0.16 0.01
12 15.406 Succinic acid DiCAc −1.00 −0.27 1.07 2.25
16 16.774 Hydrocinnamic acid PhePr −1.00 −0.15 −0.30 0.05
22 17.95 2,4-Ditert-butylphenol Phenolic −0.40 0.39 0.52 −0.16
24 18.168 Pyroglutamic acid Amino acid −0.78 0.00 0.17 1.29
32 19.52 p-Hydroxyphenylacetic 
acid
Ar-acid −0.75 −0.27 −0.36 0.19
37 20.438 10-Undecenoic acid FA −0.75 0.01 1.03 −0.68
38 20.51 Benzenepropanoic acid PhePr −0.95 −0.28 −0.32 −0.24
39 21.051 Glycerol phosphate Others −0.98 −0.07 −0.16 0.24
40 21.159 Tetradecanoic acid, 
12-methyl, methyl ester
FAME −0.31 0.02 0.58 2.27
43 21.583 
21.652
D-Fructose CHO −0.93 −0.88 0.36 −0.57
44 21.345 Tetradecanoic acid FA −0.57 0.12 0.01 0.18
46 22.039 Adenine Nucleobase −0.92 −0.34 0.08 0.36
48 22.716 Pentadecanoic acid FA −0.68 −0.12 −0.04 0.48
ID RT Compound Family
99 32.551 α-Tocopherol Vitamin
100 32.768 Cholesterol Sterol
101 33.336 Lanosterol Sterol
102 33.852 Campesterol Sterol
103 34.207 Stigmasterol Sterol
104 34.346 Chenodeoxycholic acid Bile salt
105 34.563 Xi-Ergost-7-ene, 3β- Sterol
106 34.918 β-Sitosterol Sterol
107 35.064 24-Ethylcoprostanol Sterol
108 35.268 trans-Dehydroandrosterone Steroid
109 38.518 Urs-12-en-28-al, 3-(acetyloxy)-, (3β)- Sterol
Some metabolites have more than one retention time (RT) due to the presence of isomers. SCFA, short-chain fatty 
acid; FA, fatty acid; FAME, fatty acid methyl ester; CHO, carbohydrate; αOH, alfa-hydroxy; βOH, beta-hydroxy; 
DiCAc, dicarboxylic acid; PyrCAc, pyridine carboxylic acid; ωOH, omega-hydroxy; Cy, cyclic; Ar, aromatic; PhePr, 
phenylpropanoid; TCA, tricarboxylic acid; IndolAc, indolic acid.
Table 1. 
Metabolites identified in the feces of mice.
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Besides, hierarchical clustering analysis (Figure 2) revealed that HF group had a 
very low content of most identified metabolites, with exception of cholesterol and 
oleic acid. In addition, the bile salt chenodeoxycholic acid was detected exclusively 
in the HF treatment, and although it was not included in the hierarchical analysis 
since it was not detected in any other treatment, this metabolite could be used a 
biomarker for HF diet.
Interestingly, only HF-ST + I mice presented a high content of cholesterol and 
oleic acid in its feces; therefore, in the heatmap, this group appears very close to HF 
(Figure 2). Moreover, HF-ST treatment is closely linked to ST group due to similar 
content of all evaluated compounds. While, HF-ST + A group is located as the link 
between HF-ST + I and the cluster of standard diets (HF-ST and ST Figure 2).
In contrast to HF-ST group, HF-ST + A and HF-ST + I exhibited an enrichment 
of the following acids: succinic, β-hydroxybutyric (BHB), α-hydroxyvaleric, and 
pyroglutamic; as well as 12-methyl-tetradecanoic acid methyl ester and adenine, 
which could be used as biomarkers for mice groups with prebiotics.
On the other hand, HF-ST + A mice showed the highest content of 2-decenal, 
10-undecenoic acid (UDA), cyclohexanol, and fructose as well as the lowest lev-
els of oleic acid and cholesterol compared to HF, HF-ST, and HF-ST + I groups; 
hence, these metabolites might be used as biomarkers for agavins prebiotic. While, 
HF-ST + I mice had an increment of three methyl esters: linoleic, oleic, and stearic 
ID RT Compound Family Fold change
HF HF-ST HF-ST + A HF-ST + I
49 21.966 
22.483 
23.336
D-Glucose CHO −0.98 −0.40 0.02 0.47
53 24.128 Linoleic acid, methyl 
ester
FAME −1.00 0.02 0.01 2.94
54 24.177 Oleic acid, methyl ester FAME −1.00 −0.07 −0.15 1.90
56 24.399 Stearic acid, methyl 
ester
FAME −0.60 −0.15 0.02 1.15
58 25.102 5-Hydroxyindoleacetic 
acid
IndolAc −1.00 0.57 0.86 1.38
59 25.198 Linoleic acid FA −0.71 −0.12 −0.41 0.34
60 25.25 Oleic acid FA 0.34 −0.09 −0.35 0.18
81 28.62 Docosanoic acid FA −0.55 −0.01 −0.03 0.25
98 31.891 Coprostan-3-ol Sterol −0.08 0.21 0.54 1.53
100 32.768 Cholesterol Sterol 0.52 −0.09 −0.35 0.27
103 34.207 Stigmasterol Sterol −0.13 −0.17 −0.47 0.04
106 34.918 β-Sitosterol Sterol −0.75 −0.14 −0.44 −0.04
107 35.064 24-Ethylcoprostanol Sterol −0.86 −0.12 −0.29 −0.09
Fold change value was calculated by comparison with the healthy mice fed with a standard diet (ST). HF, overweight 
mice; HF-ST, overweight mice that were switched to a standard diet; HF-ST + A, overweight mice changed to 
standard diet plus agavins; HF-ST + I, overweight mice changed to standard diet plus inulins. All the metabolites 
listed here have significant difference at least in one treatment p < 0.5. ID numbers correspond with those of Table 1. 
SCFA, short-chain fatty acid; FA, fatty acid; FAME, fatty acid methyl ester; CHO, carbohydrate; αOH, alfa-hydroxy; 
βOH, beta-hydroxy; DiCAc, dicarboxylic acid; Ar, aromatic; PhePr, phenylpropanoid; IndolAc, indolic acid.
Table 2. 
Fold-change of differential metabolites detected in the feces of overweight mice after a diet switch and prebiotic 
supplementation.
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Figure 1. 
Metabolites enriched or depleted in the feces of overweight mice after a diet shift and prebiotic supplementation. 
(A) PCA and (B) loading plot of the two first PCs. Overweight mice (HF) after a diet change (HF-ST) and 
agavins (HF-ST + A) or inulins (HF-ST + I) supplementation. ST was a healthy mice group.
Figure 2. 
Heatmap of differential metabolites found in the feces of overweight mice after a diet shift and prebiotic 
supplementation. HF, overweight mice; HF-ST, overweight mice after a diet shift; HF-ST + A, overweight mice 
that were switched to standard diet plus agavins supplement; HF-ST + I, overweight mice that were switched to 
standard diet plus inulins supplement. ST was a healthy mice group.
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acid in relation to the other mice groups. These results evidence a clear difference in 
the fecal metabolites profiles between agavins and inulins, which was associated to 
their structural differences, such as the presence of fructose observed exclusively in 
HF-ST + A group. Agavins structure presents at least four terminal fructose units, 
so that some gut bacteria might start breaking down this prebiotic releasing fruc-
tose and agavins of smaller degree of polymerization [30]. In addition, 2-decenal 
and UDA were the metabolites mostly enriched with agavins intake. 2-decenal has a 
broad antimicrobial spectrum against pathogenic bacteria [31], while UDA is a neu-
roprotectant compound [32, 33] used as a nutritional supplement for maintaining a 
healthy balance of gut microbiota [34]. Besides, UDA also might be acting through 
GPR84 (a newly described medium chain fatty acid receptor) associated to immu-
nological responses [35], and this mechanism could also contribute to improve the 
host health. Whereas in comparison to agavins, inulins led to a significant increase 
of methyl esters and sterols, coinciding with previous studies which proposed this 
event as a mechanism to improve the lipid metabolism of host [36, 37].
3.2 Organic acid profiles
A total of 21 organic acids were identified, including SCFA, hydroxy-SCFA, 
dicarboxylic acids, and aromatic carboxylic acids (Table 3). PCA analysis of organic 
acids showed the HF group in a separate cluster, while standard diets (HF-ST and 
ST) displayed an overlap due to presence of similar metabolites in both groups 
(Figure 3A). In addition, PCA and the loading plot evidenced that HF-ST + A and 
HF-ST + I groups had a more similar organic acids profiles among them in relation 
to the other diets (Figure 3B).
Moreover, hierarchical clustering analysis evidenced that HF group had the low-
est content of all organic acids, while HF-ST + A mice exhibited the highest content 
of the majority of them; therefore, this group is located at one end of the heatmap 
(Figure 4). Noticeably, HF-ST + I group showed various metabolites with a similar 
content as HF group; for instance the following acids: 2 methyl butanoic, lactic, 
and hexanoic (Table 3); hence, HF-ST + I appears very close to HF group in the 
heatmap (Figure 4). Once again, HF-ST and ST are the closes groups because they 
presented similar levels of most analyzed organic acids.
Interestingly, and despite that the hierarchical analyses locate fructans diets very 
distant from each other (in addition to the great structural differences between 
agavins and inulins), HF-ST + A and HF-ST + I groups showed an increment of 
the following acids: succinic, BHB, α-hydroxyisovaleric, and α-hydroxyglutaric. 
Stunningly, succinic acid is involved in glucose homeostasis [38], while BHB has 
a neuroprotective effect in mice [39] as well as may inhibit the release of fatty 
acids from adipose tissue by the hydroxy-carboxylic acid receptor 2 (HCA2) [40]. 
Then, these metabolites might be employed in general as biomarkers of prebiotic 
supplementation.
On the other hand, only agavins supplementation led to a notably enrichment of 
four acids: nicotinic, 3-phenyllactic, 5-hydroxyvaleric, and lactic; therefore, these 
metabolites could be used as specifics biomarkers for this prebiotic. It is known that 
nicotinic acid also stimulate the HCA2, thereby decreasing plasma lipids and pro-
tecting against atherosclerotic disorders [41], and this event could be contributing 
to improve lipid metabolism of overweight mice that we previously reported [10]. 
Whereas 3-phenyllactic (the metabolite with the highest increment after agavins 
consumption) is synthesized by Lactobacillus strains and exerts direct antipatho-
genic activities against bacteria, viruses, and fungi [42].
Surprisingly, we did not find any differential abundance of any organic acid 
with inulins intake.
Metabolomics - New Insights into Biology and Medicine
12
Figure 3. 
Organic acids detected in the feces of overweight mice after a diet shift and prebiotic supplementation.  
(A) PCA and (B) loading plot of the two first PCs. Overweight mice (HF) after a diet change (HF-ST) and 
agavins (HF-ST + A) or inulins (HF-ST + I) supplementation. ST was a healthy mice group.
Figure 4. 
Hierarchically clustered heatmap of organic acids found in the feces of overweight mice after a diet shift and 
prebiotic supplementation. HF, overweight mice; HF-ST, overweight mice after a diet shift; HF-ST + A, 
overweight mice that were switched to standard diet plus agavins supplement; HF-ST + I, overweight mice that 
were switched to standard diet plus inulins supplement. ST was a healthy mice group.
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4. Conclusions
Microbial metabolites found in agavins group exhibited greater similarity to 
healthy mice, plus enrichment of specific metabolites (biomarkers) such as 2-decenal, 
UDA, cyclohexanol, fructose as well as some organic acids that undoubtedly are 
ID RT Compound Family tFold change
HF HF-ST HF-ST + A HF-ST + I
110 11.015 Butanoic acid, 2-methyl SCFA −0.46 −0.15 −0.38 −0.32
111 12.382 n-Pentanoic acid SCFA −0.71 0.07 −0.37 −0.23
112 14.666 Lactic acid αOH-
SCFA
−1.00 −0.41 0.05 −0.89
113 14.826 n-Hexanoic acid SCFA −0.66 0.12 −0.27 −0.54
114 15.028 Hydroxyacetic acid αOH-
SCFA
−0.89 −0.08 0.00 −0.39
3 17.177 β-Hydroxybutyric acid βOH-
SCFA
−0.74 −0.98 0.62 0.23
115 17.312 α-Hydroxyisovaleric acid αOH-
SCFA
−0.86 −0.44 2.26 0.11
116 18.248 Malonic acid DiCAc −0.53 0.08 0.29 0.18
117 20.133 Nicotinic acid PyrCAc −0.80 −0.18 0.56 −0.06
12 20.773 Succinic acid DiCAc −0.88 0.01 2.01 0.96
118 21.186 5-Hydroxyvaleric acid ωOH-
SCFA
−1.00 −0.18 0.51 −0.40
119 21.483 Fumaric acid DiCAc −1.00 0.29 1.05 0.38
120 26.404 α-Hydroxyglutaric acid αOH-
SCFA
−1.00 −0.24 0.88 0.39
121 26.483 3-Phenyllactic acid αOH-
Ar-
SCFA
−0.80 −0.32 0.66 −0.32
122 26.993 p-Hydroxycyclohexaneacetic 
acid
OH-Cy-
SCFA
−0.80 −0.15 −0.07 −0.53
32 27.406 p-Hydroxyphenylacetic acid OH-Ar-
SCFA
−0.98 −0.02 −0.17 −0.55
123 28.745 m-Hydroxyphenylpropanoic 
acid
PhePr −0.95 −0.02 −0.10 −0.51
124 29.137 cis-Aconitic acid TCA −1.00 0.06 1.62 3.48
125 29.186 p-Hydroxyhydrocinnamic 
acid
PhePr −0.62 0.04 0.18 −0.09
41 29.634 Azelaic acid DiCAc −0.69 0.20 0.25 −0.41
58 29.2929 5-Hydroxyindoleacetic acid IndolAc −0.90 −0.40 −0.03 −0.22
Fold change value was calculated by comparison with the healthy mice fed with a standard diet (ST). HF, 
overweight mice; HF-ST, overweight mice that were switched to a standard diet; HF-ST + A, overweight mice 
changed to standard diet plus agavins; HF-ST + I, overweight mice changed to standard diet plus inulins. All the 
metabolites listed here have significant difference at least in one treatment p < 0.5. ID numbers correspond with 
those of Table 1. SCFA, short-chain fatty acid; αOH, alfa-hydroxy; βOH, beta-hydroxy; DiCAc, dicarboxylic acid; 
PyrCAc, pyridine carboxylic acid; ωOH, omega-hydroxy; Cy, cyclic; Ar, aromatic; PhePr, phenylpropanoid; TCA, 
tricarboxylic acid; IndolAc, indolic acid.
Table 3. 
Fold-change of differential organic acids detected in the feces of overweight mice after a diet switch and 
prebiotic supplementation.
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playing a very important role on overweight mice health. For instance, 2-decenal pos-
sess antimicrobial properties; UDA is a neuroprotectant compound; nicotinic acid can 
decrease plasma lipids levels; while 3-phenyllatic acid shown antipathogenic activities 
versus bacteria, viruses and fungi. Nevertheless, further studies are needed to clarify 
the underlying mechanisms by which metabolites derived from agavins fermenta-
tion induce a beneficial effect on health of host. Finally, these findings open new and 
exciting opportunities to explore new biomarkers with applicability on prevention, 
therapy, or treatment of overweight people.
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Nomenclature
HF overweight mice
HF-ST overweight mice that were switched to a standard diet
HF-ST + A overweight mice changed to standard diet plus agavins
HF-ST + I overweight mice changed to standard diet plus inulins
ST healthy mice
SCFA short-chain fatty acids
GC/MS gas chromatography/mass spectrometry
BHB β-hydroxybutyric acid
UDA 10-undecenoic acid
PCA principal component analysis
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